Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation

被引:59
作者
Jain, A
Ma, CA
Lopez-Granados, E
Means, G
Brady, W
Orange, JS
Liu, SY
Holland, S
Derry, JMJ [1 ]
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[2] Amgen Inc, Seattle, WA USA
[3] Childrens Hosp, Div Immunol, Boston, MA 02115 USA
关键词
D O I
10.1172/JCI200421345
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Hypomorphic mutations in the zinc finger domain of NF-kappaB essential modulator (NEMO) cause X-linked hyper-IgM syndrome with ectodermal dysplasia (XHM-ED). Here we report that patient B cells are characterized by an absence of Ig somatic hypermutation (SHM) and defective class switch recombination (CSR) despite normal induction of activation-induced cytidine deaminase (AID) and Iepsilon-Cepsilon transcripts. This indicates that AID expression alone is insufficient to support neutralizing antibody responses. Furthermore, we show that patient B cells stimulated with CD40 ligand are impaired in both p65 and c-Rel activation, and whereas addition of IL-4 can enhance p65 activity, c-Rel activity remains deficient. This suggests that these NF-kappaB components have different activation requirements and that IL-4 can augment some but not all NEMO-dependent NF-kappaB signaling. Finally, using microarray analysis of patient B cells we identified downstream effects of impaired NF-kappaB activation and candidate factors that may be necessary for CSR and SHM in B cells.
引用
收藏
页码:1593 / 1602
页数:10
相关论文
共 41 条
[1]   Leukocyte transfusion-associated granulocyte responses in a patient with X-linked hyper-IgM syndrome [J].
Atkinson, TP ;
Smith, CA ;
Hsu, YM ;
Garber, E ;
Su, LH ;
Howard, TH ;
Prchal, JT ;
Everson, MP ;
Cooper, MD .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (06) :430-439
[2]   Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions [J].
Chirmule, N ;
Tazelaar, J ;
Wilson, JM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (01) :248-255
[3]   CD40 regulates the processing of NF-κB2 p100 to p52 [J].
Coope, HJ ;
Atkinson, PGP ;
Huhse, B ;
Belich, M ;
Janzen, J ;
Holman, MJ ;
Klaus, GGB ;
Johnston, LH ;
Ley, SC .
EMBO JOURNAL, 2002, 21 (20) :5375-5385
[4]   Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFκB [J].
Dedeoglu, F ;
Horwitz, B ;
Chaudhuri, J ;
Alt, FW ;
Geha, RS .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (03) :395-404
[5]   Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades [J].
Digicaylioglu, M ;
Lipton, SA .
NATURE, 2001, 412 (6847) :641-647
[6]   NF-κB signaling:: Many roads lead to Madrid [J].
Dixit, V ;
Mak, TW .
CELL, 2002, 111 (05) :615-619
[7]   X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling [J].
Döffinger, R ;
Smahi, A ;
Bessia, C ;
Geissmann, F ;
Feinberg, J ;
Durandy, A ;
Bodemer, C ;
Kenwrick, S ;
Dupuis-Girod, S ;
Blanche, S ;
Wood, P ;
Rabia, SH ;
Headon, DJ ;
Overbeek, PA ;
Le Deist, F ;
Holland, SM ;
Belani, K ;
Kumararatne, DS ;
Fischer, A ;
Shapiro, R ;
Conley, ME ;
Reimund, E ;
Kalhoff, H ;
Abinun, M ;
Munnich, A ;
Israël, A ;
Courtois, G ;
Casanova, JL .
NATURE GENETICS, 2001, 27 (03) :277-285
[8]   De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination [J].
Doi, T ;
Kinoshita, K ;
Ikegawa, M ;
Muramatsu, M ;
Honjo, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2634-2638
[9]  
Early GS, 1996, J IMMUNOL, V157, P3159
[10]   Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 [J].
Ferrier, R ;
Nougarede, R ;
Doucet, S ;
Kahn-Perles, B ;
Imbert, J ;
Mathieu-Mahul, D .
ONCOGENE, 1999, 18 (04) :995-1005